Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer
Authors:
Open Access
- 2 October 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 85 (7) , 1047-1054
Abstract
Expression of membrane-bound Fas ligand (mFasL) on colon cancer cells serves as a potential mechanism to inhibit host immune function by inducing apoptosis of host lymphocytes. Membrane-bound FasL can be cleaved and released as a soluble mediator (sFasL), which may spread the apoptosis induction effect. Our study examined whether colon adenocarcinoma cells release sFasL, and induce apoptosis of host lymphocytes without direct cell–cell contact. In 12 consecutive patients with colon adenocarcinoma mFasL was identified in the tumours, sFasL was measured in the sera and apoptosis identified in tumour-infiltrating and peripheral blood lymphocytes. To analyse the function of sFasL, colon cancer cells were primarily cultured; sFasL was isolated from supernatants, measured, incubated with Fas-bearing Jurkat cells, and the resulting apoptosis was analysed. Serum levels of sFasL were significantly elevated in all colon cancer patients with mFasL expression in tumour tissues (n = 8). In these patients, the number of apoptotic lymphocytes was significantly increased within tumour and peripheral blood. Furthermore, sFasL was present in the corresponding supernatants and induced apoptosis of Jurkat cells in a dose-dependent manner. These findings suggest that mFasL-positive colon cancer cells release sFasL, and thus may induce apoptosis of host lymphocytes as a potential mechanism for immune evasion. © 2001 Cancer Research Campaign http://www.bjcancer.comKeywords
This publication has 42 references indexed in Scilit:
- Malaria Infection Induces Rapid Elevation of the Soluble Fas Ligand Level in Serum and Subsequent T Lymphocytopenia: Possible Factors Responsible for the Differences in Susceptibility of Two Species ofMacacaMonkeys toPlasmodium coatneyiInfectionInfection and Immunity, 2000
- Comparison of the Effects of Immunosuppressive Factors from Newly Established Colon Carcinoma Cell Cultures on Human Lymphocyte Proliferation and Cytokine SecretionTumor Biology, 2000
- Soluble Fas ligand expression in the ocular fluids of uveitis patientsCurrent Eye Research, 2000
- Requirement of Cell–Cell Contact in the Induction of Jurkat T Cell Apoptosis: The Membrane-Anchored but Not Soluble Form of FasL Can Trigger Anti-CD3-Induced Apoptosis in Jurkat T CellsBiochemical and Biophysical Research Communications, 1997
- CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.Journal of Clinical Investigation, 1997
- An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligandBritish Journal of Haematology, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Fas ligand mediates activation-induced cell death in human T lymphocytes.Journal of Experimental Medicine, 1995
- The Role of APO‐1‐Mediated Apoptosis in the Immune SystemImmunological Reviews, 1994